Lung CancerELFENCT06351085
Enhancing Lung Cancer Screening Through Human-Centered Intervention
A study testing Pre-Visit Planner and Pre-Visit Planner + MyChart in people with Lung Cancer, run by University of California, Davis at 1 site in United States.
Trial summary
The purpose of this study is to further understand the factors involved in increasing lung cancer screening. Read more about this study
- Who is it for?
- Ages 50 to 80 yearsHealthy volunteers can take part
- Conditions the study is for
- Lung Cancer
- What is being tested?
- Pre-Visit Planner and Pre-Visit Planner + MyChart
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 2,869 participants
- Where
- 1 siteUnited States
- Study dates
- 10 Nov 2022to 31 Dec 2026
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 50 to 80 years
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Interviews:
- UC Davis Health Systems (UCDHS) primary care providers and clinic staff who provide services to patients ages 50-80.
- Patients who are eligible for lung cancer screening.
- Screening Intervention:
- Patients ages 50-80 who have a history of smoking per review of their electronic medical record and who receive care at the following UCDH ambulatory care clinics: Ellison Ambulatory Care Clinic; Elk Grove; Midtown.
Who cannot join
- Interviews:
- Non-consenting patients and patients who do not speak English or Spanish
- Patients aged 49 and younger
- Non UCDHS primary care providers and clinic staff
- Screening Intervention:
- UCDHS patients who have already received Lung Cancer Screening
- Patients with existing Cancer diagnosis
Trial locations and contacts
1 site in 1 country.
United States1 site
University of California, Davis
Sacramento, California, 95817
About this study
The purpose of this study is to further understand the factors involved in increasing lung cancer screening.
Read the detailed description
The study aims to identify patient, primary care team and health system factors that facilitate participation in lung cancer screening. Additionally, conduct a two-arm randomized comparative effectiveness intervention study to increase lung cancer screening compared with a usual care control arm and further evaluate the differential impact of the intervention conditions compared to usual care.
- Conditions
- Lung Cancer
- Being tested
- Pre-Visit Planner, Pre-Visit Planner + MyChart
- Keywords
- Lung Cancer Screening
- Medical subject headings
- Lung Neoplasms
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Pre-Visit PlannerBehavioural
The study is comparing the implementation of a Pre-Visit Planner to go through the shared decision making process.
Pre-Visit Planner + MyChartBehavioural
The study is comparing the implementation of a Pre-Visit Planner to go through the shared decision making process as well as testing if watching educational videos about the Lung Cancer Screening (LCS) process prior to talking to an LVN will help with LCS uptake.
| Study group | Role | What they receive |
|---|---|---|
| Pre-Visit Planner (PVP) | Other | A Licensed Vocational Nurse (LVN) will verify patient smoking history and calculate pack years with the patient over the phone. Receives: Behavioral: Pre-Visit Planner |
| Pre-Visit Planner (PVP) + MyChart | Other | A Licensed Vocational Nurse (LVN) will verify patient smoking history and calculate pack years with the patient over the phone. In addition, the patient will receive educational video through MyChart prior to an LVN calling. Receives: Behavioral: Pre-Visit Planner + MyChart |
| Usual Care | No intervention | Patients will receive usual care. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Lung Cancer Screening
The primary outcome is the proportion of patients aged 50-80 with a history of smoking who receive Lung Cancer Screening during the study period; this outcome will be measured in both intervention groups and the control group.
Measured: 156 Weeks
Secondary outcomes (1)
Completion of Interviews with Staff and Patients
Key informant interviews with UC Davis staff and patients to determine approach to intervention.
Measured: 156 Weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted8 Apr 2024
- Study start10 Nov 2022
- Primary completion31 Dec 2026 (estimated)
- Study completion31 Dec 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Lung CancerStudies of the same condition, open and under way.
- More trials run by University of California, DavisThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Screening
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- Patients of the intervention clinics will be assigned one of two interventions: 1) Pre Visit Planner (PVP) or 2) PVP + patient education delivered via the MyUCDHealth patient web portal.
- Masking
- Single blind
- Who is masked
- Participant
- Enrolment
- 2,869 participants (actual)
Sponsor and investigators
- Lead sponsor
- University of California, Davis
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06351085
- Sponsor's protocol ID
- 1937769
- Acronym
- ELFE
- Status last verified
- May 2026
- First submitted
- 26 Mar 2024
- Last updated
- 8 May 2026
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 8 May 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Enhancing Lung Cancer Screening Through Human-Centered Intervention
- ClinicalTrials.gov ID
- NCT06351085
- Acronym / sponsor ID
- ELFE / 1937769
- Conditions
- Lung Cancer
- Keywords
- Lung Cancer Screening
- Study type
- Interventional
- Recruitment status
- Active, not recruiting
- Enrolment
- 2,869 participants (actual)
- Lead sponsor
- University of California, DavisUniversity, hospital or other
- Study start
- 10 Nov 2022 (actual)
- Primary completion
- 31 Dec 2026 (estimated)
- Study completion
- 31 Dec 2026 (estimated)
- First posted
- 8 Apr 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The purpose of this study is to further understand the factors involved in increasing lung cancer screening.
Detailed description
The study aims to identify patient, primary care team and health system factors that facilitate participation in lung cancer screening. Additionally, conduct a two-arm randomized comparative effectiveness intervention study to increase lung cancer screening compared with a usual care control arm and further evaluate the differential impact of the intervention conditions compared to usual care.
Study design
- Primary purpose
- Screening
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (participant)
- Number of arms
- 3
- Model description
- Patients of the intervention clinics will be assigned one of two interventions: 1) Pre Visit Planner (PVP) or 2) PVP + patient education delivered via the MyUCDHealth patient web portal.
| Arm | Type | Receives |
|---|---|---|
| Pre-Visit Planner (PVP) | Other | Behavioral: Pre-Visit PlannerA Licensed Vocational Nurse (LVN) will verify patient smoking history and calculate pack years with the patient over the phone. |
| Pre-Visit Planner (PVP) + MyChart | Other | Behavioral: Pre-Visit Planner + MyChartA Licensed Vocational Nurse (LVN) will verify patient smoking history and calculate pack years with the patient over the phone. In addition, the patient will receive educational video through MyChart prior to an LVN calling. |
| Usual Care | No intervention | –Patients will receive usual care. |
Who may qualify
- Ages
- 50 to 80 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (5 listed)
- UC Davis Health Systems (UCDHS) primary care providers and clinic staff who provide services to patients ages 50-80.
- Patients who are eligible for lung cancer screening.
- Patients ages 50-80 who have a history of smoking per review of their electronic medical record and who receive care at the following UCDH ambulatory care clinics: Ellison Ambulatory Care Clinic; Elk Grove; Midtown.
Key exclusion criteria (7 listed)
- Non-consenting patients and patients who do not speak English or Spanish
- Patients aged 49 and younger
- Non UCDHS primary care providers and clinic staff
- UCDHS patients who have already received Lung Cancer Screening
- Patients with existing Cancer diagnosis
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Pre-Visit PlannerThe study is comparing the implementation of a Pre-Visit Planner to go through the shared decision making process. | Behavioural | Pre-Visit Planner (PVP) |
| Pre-Visit Planner + MyChartThe study is comparing the implementation of a Pre-Visit Planner to go through the shared decision making process as well as testing if watching educational videos about the Lung Cancer Screening (LCS) process prior to talking to an LVN will help with LCS uptake. | Behavioural | Pre-Visit Planner (PVP) + MyChart |
Primary outcome
Lung Cancer Screening
Time frame: 156 Weeks
The primary outcome is the proportion of patients aged 50-80 with a history of smoking who receive Lung Cancer Screening during the study period; this outcome will be measured in both intervention groups and the control group.
1 secondary outcome
Completion of Interviews with Staff and Patients
Time frame: 156 Weeks
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 8 May 2026.
- Individual participant dataSharing planned: No
Related trials for Lung Cancer
RecruitingPhase 2
A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer
Carcinoma, Non-small-Cell Lung
RecruitingPhase 1/2
FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC
Ovarian Cancer, Non-small Cell Lung Cancer
Active, not recruiting
Copper Cu 64-DOTA-Trastuzumab PET in Predicting Response to Treatment With Ado-Trastuzumab Emtansine in Patients With Metastatic HER2 Positive Breast Cancer
Bone Metastases, HER2-positive Breast Cancer
Not yet recruitingObservational study
The Impact of Rheumatoid Arthritis Treatments on the Modulation of Extracellular Vesicles and Other Biomarkers Involved in the Development of Lung Cancer
Rheumatoid Arthritis (RA), Lung Neoplasms
Active, not recruitingPhase 3
A Study of Lazertinib With Subcutaneous Amivantamab Compared With Intravenous Amivantamab in Participants With Epidermal Growth Factor Receptor (EGFR)-Mutated Advanced or Metastatic Non-small Cell Lung Cancer
Advanced or Metastatic Non-small Cell Lung Cancer
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Pre-Visit Planner and Pre-Visit Planner + MyChart in people with Lung Cancer, run by University of California, Davis at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: under way, not looking for participants, as of the sponsor's last update on 8 May 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Lung Cancer Screening (time frame: 156 Weeks). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 May 2026; AzTrials last refreshed its copy on 3 Nov 2026.